WEHI: New findings could lead to cancer therapy without harmful side-effects

Researchers at WEHI have developed a way to potentially reduce the toxic side-effects of a type of immunotherapy, in findings that could overcome the pioneering treatment’s biggest limitation.

June 21, 2022

Researchers at WEHI have developed a way to potentially reduce the toxic side-effects of a type of immunotherapy, in findings that could overcome the pioneering treatment’s biggest limitation.

Read Transcript

Researchers at WEHI (Walter and Eliza Hall Institute) have developed a way to potentially reduce the toxic side-effects of a type of immunotherapy, in findings that could overcome the pioneering treatment’s biggest limitation. Learn more about Associate Professor Matthew Call and Associate Professor Melissa Call’s findings here.

L-R: Dr Ashleigh Davey, Associate Professor Matthew Call, Associate Professor Melissa Call, Dr Nick Chandler.

Disclaimer: HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Posted

in

Impact

on

June 21, 2022

by

,

WEHI

Researchers at WEHI (Walter and Eliza Hall Institute) have developed a way to potentially reduce the toxic side-effects of a type of immunotherapy, in findings that could overcome the pioneering treatment’s biggest limitation. Learn more about Associate Professor Matthew Call and Associate Professor Melissa Call’s findings here.

L-R: Dr Ashleigh Davey, Associate Professor Matthew Call, Associate Professor Melissa Call, Dr Nick Chandler.

Disclaimer: HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Disclaimer: This material has been prepared by WEHI, published on Jun 21, 2022. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook